Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Revenue

In the year 2024, Xeris Biopharma Holdings had annual revenue of $203.07M with 23.89% growth. Xeris Biopharma Holdings had revenue of $60.10M in the quarter ending December 31, 2024, with 35.39% growth.

• Revenue (ttm): $203.07M
• Revenue Growth: +23.89%
• P/S Ratio: 4.03
• Revenue / Employee: $515,406
• Employees: 394
• Market Cap: 832.82M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	203.07M	39.16M	23.89%
Dec 31, 2023	163.91M	53.67M	48.68%
Dec 31, 2022	110.25M	60.66M	122.32%
Dec 31, 2021	49.59M	29.16M	142.67%
Dec 31, 2020	20.44M	17.71M	650.73%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.